VXRT
Vaxart, Inc.
Vaxart, Inc. (VXRT) has 18 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 20, 2026.
- Industry:Biotechnology
- CEO:Steven Lo
- Employees:105
- HQ:South San Francisco, CA, US
- IPO:1981-12-11
Insider Buying
$7K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$116.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Watson W. MarkFirst filing | Director | Purchase | 10,000 | $7K | May 26 | SEC ↗ |
Related companies
Vaxart, Inc. is in the Healthcare sector.